norfenfluramine has been researched along with Familial Primary Pulmonary Hypertension in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dempsie, Y; Loughlin, L; MacLean, MR; MacRitchie, NA; Mair, KM; Morecroft, I; Nilsen, M; White, K; Wright, AF | 1 |
1 other study(ies) available for norfenfluramine and Familial Primary Pulmonary Hypertension
| Article | Year |
|---|---|
Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.
Topics: Animals; Arterial Pressure; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP1B1; Dexfenfluramine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Familial Primary Pulmonary Hypertension; Female; Hypertension, Pulmonary; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Norfenfluramine; Ovariectomy; Pulmonary Artery; Serotonin; Sex Factors; Tryptophan Hydroxylase; Ventricular Function, Right; Ventricular Pressure | 2013 |